Alloplex Biotherapeutics has filed a notice of an exempt offering of securities to raise $25 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Alloplex Biotherapeutics is raising $25,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Francescopaolo Borriello played a key role in…